| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.67B | -9.7% |
| Cost of Revenue | $2.09B | -12.1% |
| R&D Expense | $3.2M | +3.2% |
| SG&A Expense | $356.8M | +3.6% |
| Operating Income | $19.2M | -25.3% |
| Interest Expense | $64.5M | -7.9% |
| Pre-tax Income | -$44.5M | -4.5% |
| Income Tax | $6.4M | -50.0% |
| Net Income | -$50.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.2M | -44.8% |
| Accounts Receivable | $273.2M | -13.6% |
| Inventory | $162.4M | -9.2% |
| Current Assets | $534.3M | -9.1% |
| Total Assets | $1.30B | -14.0% |
| Current Liabilities | $698.7M | -11.6% |
| Long-term Debt | $377.1M | -26.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $112.9M | -23.5% |
| Capital Expenditures | $57.2M | -19.2% |
| Investing Cash Flow | $12.7M | +127.4% |
| Financing Cash Flow | -$149.1M | -102.6% |
| Free Cash Flow | $55.7M | -27.5% |
| +8.1% |
| EPS (Basic) | -$1.07 | +6.1% |
| EPS (Diluted) | -$1.07 | +6.1% |
| Total Liabilities |
| $1.25B |
| -10.1% |
| Stockholders' Equity | $49.9M | -58.2% |